Targeted Immunotherapy with Rituximab Leads to a Transient Alteration of the IgG Autoantibody Profile in Pemphigus Vulgaris
Ralf Müller(Philipps University of Marburg), Michael Hertl(Universitätsklinikum Gießen und Marburg), Rüdiger Eming(Philipps University of Marburg), Nicolas Hunzelmann(University Hospital Cologne), P. Joly(Inserm), Guido Siebenhaar(University of Cologne), Elke Wenzel(Philipps University of Marburg), Philippe Musette(Université Sorbonne Paris Nord), A. Niedermeier(Philipps University of Marburg), Vera Baur(Philipps University of Marburg)
Cited by 29
Related Papers
Mapping and predicting mortality from systemic sclerosis
|Annals of the Rheumatic Diseases|2017|699
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
|Journal of the American Academy of Dermatology|2008|597
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
|Journal of the American Academy of Dermatology|2018|384
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
|Journal of the American Academy of Dermatology|2011|379
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
|Journal of the European Academy of Dermatology and Venereology|2020|332